Abstract
Brachytherapy Devices - Global Opportunity Assessment, Competitive Landscape
and Market Forecasts to 2017
Summary
GlobalData’s medical equipment report, “Brachytherapy Devices -
Global Opportunity Assessment, Competitive Landscape and Market Forecasts to
2017” provides key market data on the global brachytherapy market. The
report provides global market value (USD million) for the two market
categories - permanent brachytherapy devices and temporary brachytherapy
devices. The report is a key source for the current market trends and
technology trends for brachytherapy. This report is built using data and
information sourced from proprietary databases, primary and secondary research
and in-house analysis by GlobalData’s team of industry experts.
Scope
• Key categories covered include - permanent brachytherapy
devices and temporary brachytherapy devices.
• Annualized market revenues data for 2002 to 2010, forecast
forward for 7 years to 2017.
• In-depth market trend analysis for brachytherapy market.
• 2010 company shares for permanent and temporary brachytherapy
devices markets.
• Geographic sales break up for 2010 sales: North America, Europe
and Rest of the World
• In-depth analysis of key players in the brachytherapy devices
market- Oncura, CR Bard, Core Oncology, Theragenics, Ibt Bebig, Varian and
Nucletron.
• Key mergers and acquisitions as well as key partnerships in the
global brachytherapy devices market.
Reasons to buy
• Develop business strategies by understanding the trends and
developments that are driving the brachytherapy devices market globally.
• Design and develop your product development, marketing and sales
strategies.
• Develop market-entry and market expansion strategies.
• Identify key players best positioned to take advantage of the
emerging market opportunities.
• Exploit in-licensing and out-licensing opportunities by
identifying products, most likely to ensure a robust return.
• What’s the next big thing in the brachytherapy devices
market landscape? - Identify, understand and capitalize.
• Make more informed business decisions from the insightful and
in-depth analysis of the global brachytherapy devices market and the factors
shaping it.
1 Table of contents
1 Table of contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 GlobalData Report Guidance
3 Disease Overview: Cancer
3.1 Introduction
3.2 Etiology, Signs and Symptoms of Cancer
3.2.1 Etiology of Cancer (Risk Factors of Cancer)
3.2.2 Pathophysiology
3.2.3 Signs and Symptoms of Cancer
3.3 Epidemiology of Cancer
3.3.1 Incidence of Cancer
3.3.2 Mortality and Survival Rates
3.4 Treatment Flow Model for Brachytherapy for Cancer
3.4.1 Diseased Patient Population
3.4.2 Treatment seeking rate
3.4.3 Diagnosis rate
3.4.4 Prescription rate
3.5 Cancer Staging
3.6 Device Based Treatment Modalities
3.6.1 Internal Radiation Therapy or Brachytherapy
3.7 Profile of Common Types of Cancer Treated by Brachytherapy
3.7.1 Prostate Cancer
3.7.2 Breast Cancer
4 Brachytherapy Devices: Market Characterization
4.1 Brachytherapy Devices Market, Global, Revenue ($m), Historic, 2003-2010
4.2 Brachytherapy Devices Market, Global, Revenue ($m), Forecasts, 2010-2017
4.3 Brachytherapy Devices Market, Global, Category Analysis, 2003-2017
4.3.1 Permanent Brachytherapy Devices Market, Global, Revenue ($m), Historic,
2003-2010
4.3.2 Permanent Brachytherapy Devices Market, Global, Revenue ($m), Forecast,
2010-2017
4.3.3 Permanent Brachytherapy Devices Market, Global, Company Share (%), 2010
4.3.4 Temporary Brachytherapy Devices Market, Global, Revenue ($m), Historic,
2003-2010
4.3.5 Temporary Brachytherapy Devices Market, Global, Revenue ($m), Forecast,
2010-2017
4.3.6 Temporary Brachytherapy Devices Market, Global, Company Share (%), 2010
4.4 Brachytherapy Devices Market, Geographic Assessment, 2010
4.5 Brachytherapy Devices Market, Global, Key Technology Trends
4.5.1 New Treatment Planning Software Reduces Treatment Time and Improves
Efficiency
4.5.2 Innovative Afterloaders to Reduce Handling Time and Improve Cost
Efficiency
4.5.3 New Radioisotopes with Short Lives
4.5.4 Image Guided Brachytherapy
4.6 Brachytherapy Devices, Market Dynamics
4.6.1 Market Drivers
4.6.2 Market Restraints
5 Brachytherapy Devices Market: Strategic Competitive Assessment
5.1 Oncura
5.1.1 Overview
5.1.2 Marketed Products
5.1.3 SWOT Analysis
5.2 CR Bard
5.2.1 Overview
5.2.2 Financial Profile
5.2.3 Marketed Products
5.2.4 SWOT Analysis
5.3 Nucletron
5.3.1 Overview
5.3.2 Financial Overview
5.3.3 Marketed Products
5.3.4 SWOT Analysis
5.4 Theragenics
5.4.1 Overview
5.4.2 Financial Overview
5.4.3 Marketed Products
5.4.4 SWOT Analysis
5.5 IBt Bebig
5.5.1 Overview
5.5.2 Marketed Products
5.5.3 Financial Overview
5.5.4 SWOT Analysis
5.6 Varian
5.6.1 Overview
5.6.2 Financial Overview
5.6.3 Marketed Products
5.6.4 SWOT Analysis
6 Brachytherapy Devices, Key Marketed Device Profiles
6.1 OncoSeed
6.2 EchoSeed
6.3 BrachySource I-125 implant
6.4 ProstaSeed I-125
6.5 TheraSeed-Pd 103
6.6 I-Seed
6.7 VariSource iX Afterloader
6.8 GammaMedplus iX Afterloader
6.9 microSelectron Digital
7 Global Brachytherapy Market: Deals Landscape
7.1 Key Acquisitions
7.1.1 IBt Bebig acquires SonoTECH GmbH
7.1.2 CR Bard to Merge with SenoRx, Inc.
7.1.3 iCAD Completes Acquisition of Xoft
7.1.4 BTG International to Acquire Biocompatibles
7.1.5 International Brachytherapy Acquires BEBIG from Eckert & Ziegler
Isotope Products
7.2 Partnerships
7.2.1 Theragenics Enters into Distribution Agreement with Oncura
7.2.2 IsoRay Enters into Exclusive Licensing Agreement with Hologic
7.2.3 Theragenics Signs an Agreement with Core Oncology
7.2.4 Nucletron Merges with Isodose Control
7.2.5 IsoRay Enters into a Distribution Agreement with Biocompatibles
International
7.2.6 Sirtex Medical Signs Agreement with Peter MacCallum Cancer Centre
7.2.7 Sirtex Medical Signs Licensing Agreement with Synmosa Biopharma
7.2.8 Sirtex Medical Signs Licensing Marketing Agreement with HOIN MEDIBIZ
8 Appendix
8.1 Definitions
8.1.1 Radiation Therapy Devices
8.1.2 Brachytherapy Devices
8.1.3 Permanent Brachytherapy Devices
8.1.4 Temporary Brachytherapy Devices
8.2 Acronyms
8.3 Sources
8.3.1 Cancer Associations and Organizations
8.3.2 Online Journals, Websites and Trade Magazines
8.3.3 News Publications
8.3.4 Company Websites, Financial Reports, Investor Presentations and
Investor Calls
8.4 Research Methodology
8.5 Secondary Research
8.6 Primary Research
8.7 Models
8.8 Forecasts
8.9 Expert Panels
8.10 GlobalData Consulting
8.11 Contact Us
8.12 Disclaimer
1.1 List of Tables
Table 1: Risk Factors for Cancer, by Geography (%), 2008
Table 2: Incidence of Cancer, Global, Population (million), 2008-2050
Table 3: New Cancer Cases by Type, Global, Male Population, 2008
Table 4: New Cancer Cases by Type, Global, Female Population, 2008
Table 5: TNM Tumor Staging
Table 6: Cancer Staging
Table 7: Cancer Staging, SEER Classification
Table 8: Brachytherapy Classification
Table 9: Brachytherapy Devices Market, Global, Revenue ($m), 2003-2010
Table 10: Brachytherapy Devices Market, Global, Revenue ($m), 2010-2017
Table 11: Permanent Brachytherapy Devices Market, Global, Revenue ($m),
2003-2010
Table 12: Permanent Brachytherapy Devices Market, Global, Revenue ($m),
2010-2017
Table 13: Temporary Brachytherapy Devices Market, Global, Revenue ($m),
2003-2010
Table 14: Temporary Brachytherapy Devices Market, Global, Revenue ($m),
2010-2017
Table 15: Brachytherapy Devices Market, Geographic Share (%), 2010
Table 16: Incidence of Cancer, Global, Population (000s), 2002-2020
Table 17: Oncura, Brachytherapy, Marketed Products, 2010
Table 18: CR Bard, Marketed Products, 2010
Table 19: Nucletron, Marketed Products, 2010
Table 20: IBt Bebig, Marketed Products, 2010
Table 21: Varian, Brachytherapy, Marketed Products, 2010
1.2 List of Figures
Figure 1: Risk Factors for Cancer (%), 2008
Figure 2: Incidence of Cancer, Global, Population (million), 2008-2050
Figure 3: New Cancer Cases by Type, Global, Male Population (%), 2008
Figure 4: New Cancer Cases by Type, Global, Female Population (%), 2008
Figure 5: Treatment Flow Model for Brachytherapy for Cancer, Global, 2010
Figure 6: Brachytherapy Devices Market, Global, Revenue ($m), 2003-2010
Figure 7: Brachytherapy Devices Market, Global, Revenue ($m), 2010-2017
Figure 8: Permanent Brachytherapy Devices Market, Global, Revenue ($m),
2003-2010
Figure 9: Permanent Brachytherapy Devices Market, Global, Revenue ($m),
2010-2017
Figure 10: Permanent Brachytherapy Devices Market, Global, Company Share (%),
2010
Figure 11: Temporary Brachytherapy Devices Market, Global, Revenue ($m),
2003-2010
Figure 12: Temporary Brachytherapy Devices Market, Global, Revenue ($m),
2010-2017
Figure 13: Temporary Brachytherapy Devices Market, Global, Company Share (%),
2010
Figure 14: Brachytherapy Devices Market, Geographic Share (%), 2010
Figure 15: Incidence of Cancer, Global, Population (000s), 2002-2020
Figure 16: Oncura, SWOT Analysis, 2010
Figure 17: CR Bard, SWOT Analysis, 2010
Figure 18: Nucletron, SWOT Analysis, 2010
Figure 19: Nucletron, New Product Launches, 2007-2010
Figure 20: Theragenics, SWOT Analysis, 2010
Figure 21: IBt Bebig, SWOT Analysis, 2010
Figure 22: Varian, SWOT Analysis, 2010
Figure 23: Varian, Product Launches, 2007-2010
